Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure

International Journal of Dermatology

Volumn 45, Issue 9, 2006, Pages 1025-1031

  Hefazi, Mehrdad ^a,b,c   Maleki, Masoud ^a,b,c   Mahmoudi, Mahmoud ^a,b,c   Tabatabaee, Abbas ^a,b,c   Balali Mood, Mahdi ^a,b,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MUSTARD GAS;

ADULT; AGED; CLINICAL ARTICLE; COMPLEMENT FACTOR; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; DRY SKIN; ERYTHROCYTE COUNT; FLOW CYTOMETRY; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; HYPOPIGMENTATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOLOGY; INTOXICATION; IRAN; LEUKOCYTE COUNT; MALE; MICROSCOPY; REVIEW; SKIN ATROPHY; SKIN BIOPSY; SKIN HEMANGIOMA; SKIN TOXICITY; THROMBOCYTE COUNT; TOXICOLOGICAL PARAMETERS; VETERAN;

EID: 33748264898     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.03020.x     Document Type: Review

References (30)

1. Sidell FR, Urbanetti JS, Smith WJ. Vesicants. In: Zajtchuk R & Bellamy RF, eds. Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General-Department of the Army, United States of America, 1997: 197-228.
2. Prentiss AM. VesAcant Agents. In: Chemicals in Warfare: a Treatise on Chemical Warfare. New York, USA: McGraw-Hill, 1937: 177-300.
3. United Nations Security Council. Report of the mission dispatched by the Secretary General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. April 25, 1988. S/19823 and S/19823/Addendum 1. 1988, New York, USA, United Nations.
4. Marrs TC, Maynard RL, Sidell FR. Chemical Warfare Agents: Toxicology and Treatment. Chichester, UK: John Wiley and Sons, 1996.
5. Somani SM. Chemical Warfare Agents. New York, USA: Academic Press, 1992.
6. Gilman A & Philips FS. The biological actions and therapeutic applications of β-chloroethyl amines and sulfides. Science 1946; 103: 409-415.
7. Crathorn AR & Robert JJ. Mechanism of cytotoxic action of alkylating agents in mammalian cells and evidence for the removal of alkylated groups from deoxyribonucleic acid. Nature 1966; 211: 150-153.
8. Balali M. Clinical and laboratory findings in Iranian fighters with chemical gas poisoning. In: Heyndrickx, A, ed. Proceedings of the First World Congress on New Compounds in Biological and Chemical Warfare. Ghent, Belgium: Rijksuniversiteit, 1984: 254-259.
9. Balali-Mood M & Navaeian A. Clinical and paraclinical findings in 233 patients with sulfur mustard poisoning. In: Heyndrickx B, ed. Proceedings of the Second World Congress on New Compounds in Biological and Chemical Warfare. Ghent, Belgium: Rijksuniversiteit, 1986: 464-473.
10. Willems JL. Clinical management of mustard gas casualties. Ann Med Mil Belg 1989; 3: S1-S61.
11. Renshaw B. Mechanisms in Production of Cutaneous Injuries by Sulfur and Nitrogen Mustards. In: Division 9, National Defense Research Committee, Comp. Chemical Warfare Agents and Related Chemical Problems. Summary Technical Report of Division 9, NDRC 1946. Washington, DC, USA: Office of Scientific Research and Development.
12. Requena L, Requena C, Sanchez M, et al. Chemical warfare. Cutaneous lesions from mustard gas. J Am Acad Dermatol 1989; 21: 324-325.
13. Cullumbine H. Medical aspects of mustard gas poisoning. Nature 1947; 159: 151-153.
14. Zandieh T, Marzaban S, Tarabadi F, et al. Defects of cell-mediated immunity in mustard gas injury after years. (Abstract). Scan J Immunol 1990; 32: 423.
15. Hassan ZM & Ebtekar M. Immunological consequence of sulfur mustard exposure. Immunol Lett 2002; 83: 151-152.
16. Yokogama MW. Recognition of natural killer cells. Curr Opin Immunol 1993; 5: 67-73.
17. Ghotbi L & Hassan Z. The immunostatus of natural killer cells in people exposed to sulfur mustard. Int Immunopharmacol 2002; 2: 981-985.
18. Papirmeister B, Feister AJ, Robinson SI, Ford RD, eds. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications. Boca Raton, FL: CRC Press, 1991: 91-122.
19. Smith KJ, Hurst CG, Moeller RB, et al. Sulfur mustard: Its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 1995; 32: 765-776.
20. Mellor SG, Rice P, Cooper GJ. Vesicant Burns. Br J Plast Surg 1991; 44: 434-437.
21. Fekri AR & Janghorbani M. Late cutaneous complications of SM poisoning in Iranian veterans. In: Proceedings of the Seminar on Late Complications of Chemical Warfare Agents in Iranian Veterans. Tehran. Iran: Veteran Foundation, 1992: 57-89.
22. Momeni A, Enshaeih S, Meghadi M, et al. Skin manifestations of mustard gas: A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992; 128: 1207-1213.
23. Chiesman WE. Diagnosis and treatment of lesions due to vesicants. Br Med J 1944; 2: 109-112.
24. Warthin AS & Weller CV. The pathology of skin lesions produced by mustard gas (dichloroethyl sulfide). J Lab Clin Med 1918; 3: 447-479.
25. Blewett WK. Tactical weapons: Is mustard still king? NBC Defense Technol Int 1986; 1: 64-66.
26. Chiesman WE. Diagnosis and treatment of lesions due to vesicants. Br Med J 1944; 2: 109-112.
27. Firooz A, Komeili A, Dowlati Y. Eruptive melanocytic nevi and cherry angiomas secondary to sulfur mustard gas. J AM Acad Dermatol 1999; 40: 646.
28. Moradi A & Aghaei S. Erupted cherry angioma secondary to exposure to mustard gas. In: Proceedings of the 7th International Congress of Dermatology. Tehran, Iran: Iranian Society of Dermatology, 2004. No.13.
29. Inada S, Hiragun K, Seo K, et al. Multiple Bowen's disease observed in former workers of a poison gas factory in Japan with special references to mustard gas exposure. J Dermatol 1978; 5: 49-60.
30. Wada S, Nishimoto Y, Miyanishi M, et al. Review of Okuno-Jima poison gas factory regarding occupational environment. Hiroshima J Med Sci 1963; 11: 75-80.